Breaking News Instant updates and real-time market news.

ARQL

ArQule

$10.84

0.42 (4.03%)

14:25
06/27/19
06/27
14:25
06/27/19
14:25

ArQule call volume above normal and directionally bullish

Bullish option flow detected in ArQule with 10,120 calls trading, 4x expected, and implied vol increasing over 5 points to 82.62%. Jul-19 12.5 calls and Oct-19 15 calls are the most active options, with total volume in those strikes near 9,000 contracts. The Put/Call Ratio is 0.04. Earnings are expected on August 1st.

  • 25

    Jun

ARQL ArQule
$10.84

0.42 (4.03%)

05/29/19
RILY
05/29/19
NO CHANGE
Target $11
RILY
Buy
ArQule price target raised to $11 from $6.75 at B. Riley FBR
B. Riley FBR analyst George Zavoico raised his price target for ArQule to $11 from $6.75 ahead of what he expects will be "positive" Phase I safety and efficacy results for ARQ531 at the European Hematology Association conference in June. The analyst reiterates a Buy rating on the shares.
06/14/19
ROTH
06/14/19
NO CHANGE
Target $13
ROTH
Buy
ArQule price target raised to $13 from $10 at Roth Capital
Roth Capital analyst Tony Butler said he is optimistic about the efficacy and safety profile of ARQ 531 following the company's presentation of trial data, investor call and his talk with management. However, he thinks the key uncertainty now is durability of responses, which he highlights as important given the refractory population and the fact that ibrutinib was also based on survival data. He has raised his view of the probability of success for ARQ 531 to 50% from 33% previously and increased his price target to $13 on ArQule shares, on which he keeps Buy rating.
06/17/19
ROTH
06/17/19
NO CHANGE
Target $20
ROTH
Buy
ArQule price target raised to $20 from $10 at Roth Capital
Roth Capital analyst Tony Butler raised his price target for ArQule to $20 from $10 after the company presented updated data from its first-in-human, single-arm Phase 1 study of ARQ 531, the first oral reversible BTK inhibitor for both wild-type and ibrutinib-resistant BTK-c481S mutation. The analyst reiterates a Buy rating on the shares.
06/19/19
RBCM
06/19/19
NO CHANGE
Target $12
RBCM
Outperform
ArQule price target raised to $12 from $10 at RBC Capital
RBC Capital analyst Gregory Ranza raised his price target on ArQule to $12 and kept his Outperform rating, citing the company's "impressive data" and "high enthusiasm" for its BTKi program ARQ 531 in B-cell malignancies demonstrated at the European Hematology Association Congress this week. The analyst adds that his new price target reflects the improving prospects for ARQ 531 success, along with his "increasing confidence" that an effective path awaits ArQule toward a "meaningful" Chronic Lymphocytic Leukemia market opportunity.

TODAY'S FREE FLY STORIES

JBLU

JetBlue

$19.37

0.41 (2.16%)

10:20
07/23/19
07/23
10:20
07/23/19
10:20
Hot Stocks
Breaking Hot Stocks news story on JetBlue »

JetBlue looking to keep…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

KMB

Kimberly-Clark

$135.13

0.73 (0.54%)

10:20
07/23/19
07/23
10:20
07/23/19
10:20
Hot Stocks
Breaking Hot Stocks news story on Kimberly-Clark »

Kimberly-Clark says…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

AAPL

Apple

$208.26

1.05 (0.51%)

, INTC

Intel

$51.37

0.01 (0.02%)

10:20
07/23/19
07/23
10:20
07/23/19
10:20
On The Fly
Qualcomm slips as Apple reportedly in talks to buy Intel modem chip business »

Shares of Qualcomm (QCOM)…

AAPL

Apple

$208.26

1.05 (0.51%)

INTC

Intel

$51.37

0.01 (0.02%)

QCOM

Qualcomm

$74.28

-1.65 (-2.17%)

SQNS

Sequans

$0.95

0.04 (4.40%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

  • 30

    Jul

  • 30

    Jul

  • 31

    Jul

  • 03

    Aug

KO

Coca-Cola

$53.76

2.51 (4.90%)

10:20
07/23/19
07/23
10:20
07/23/19
10:20
Options
Coke call volume surges as shares pop post earnings »

Coke call volume surges…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

  • 19

    Sep

KMB

Kimberly-Clark

$134.81

0.41 (0.31%)

10:17
07/23/19
07/23
10:17
07/23/19
10:17
Hot Stocks
Breaking Hot Stocks news story on Kimberly-Clark »

Kimberly-Clark says sees…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

10:17
07/23/19
07/23
10:17
07/23/19
10:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

10:16
07/23/19
07/23
10:16
07/23/19
10:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JBLU

JetBlue

$19.34

0.38 (2.00%)

10:15
07/23/19
07/23
10:15
07/23/19
10:15
Hot Stocks
JetBlue sees Q3 capacity up 3%-5%, says guidance 'unusually low' for JetBlue »

Sees Q3 RASM up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

SNAP

Snap

$14.37

0.23 (1.63%)

, TWTR

Twitter

$37.42

-0.16 (-0.43%)

10:15
07/23/19
07/23
10:15
07/23/19
10:15
Initiation
Fly Intel: Top five analyst initiations »

Catch up on today's…

SNAP

Snap

$14.37

0.23 (1.63%)

TWTR

Twitter

$37.42

-0.16 (-0.43%)

SLAB

Silicon Labs

$107.10

1.94 (1.84%)

CATC

Cambridge Bancorp

$80.70

0.94 (1.18%)

AVGO

Broadcom

$300.08

3.97 (1.34%)

ADPT

Adaptive Biotechnologies

$40.00

0.84 (2.15%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

  • 24

    Jul

  • 26

    Jul

  • 30

    Jul

  • 03

    Aug

  • 08

    Aug

  • 13

    Sep

DVN

Devon Energy

$26.02

-0.39 (-1.48%)

, SFM

Sprouts Farmers Market

$16.78

-0.5 (-2.89%)

10:15
07/23/19
07/23
10:15
07/23/19
10:15
Downgrade
Fly Intel: Top five analyst downgrades »

Catch up on today's…

DVN

Devon Energy

$26.02

-0.39 (-1.48%)

SFM

Sprouts Farmers Market

$16.78

-0.5 (-2.89%)

VIVE

Viveve

$0.15

-0.252 (-62.05%)

WPM

Wheaton Precious Metals

$27.26

0.11 (0.41%)

CADE

Cadence Bancorp

$15.78

-0.08 (-0.50%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Aug

  • 06

    Aug

  • 07

    Aug

  • 09

    Aug

  • 26

    Aug

  • 23

    Sep

  • 13

    Nov

SNAP

Snap

$14.38

0.24 (1.70%)

, MUR

Murphy Oil

$22.24

0.13 (0.59%)

10:15
07/23/19
07/23
10:15
07/23/19
10:15
Upgrade
Fly Intel: Top five analyst upgrades »

Catch up on today's…

SNAP

Snap

$14.38

0.24 (1.70%)

MUR

Murphy Oil

$22.24

0.13 (0.59%)

KPTI

Karyopharm

$8.68

0.36 (4.33%)

SNN

Smith & Nephew

$43.74

0.3 (0.69%)

COLM

Columbia Sportswear

$105.72

3.61 (3.54%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

  • 25

    Jul

  • 31

    Jul

  • 03

    Aug

  • 08

    Aug

S

Sprint

$7.00

(0.00%)

10:15
07/23/19
07/23
10:15
07/23/19
10:15
Options
Sprint put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Aug

10:15
07/23/19
07/23
10:15
07/23/19
10:15
General news
U.S. existing home sales fell 1.7% in June to a disappointing 5.270 M pace »

U.S. existing home sales…

NSANY

Nissan

$0.00

(0.00%)

10:13
07/23/19
07/23
10:13
07/23/19
10:13
Periodicals
Nissan to eliminate over 10,000 jobs globally, Kyodo News reports »

Nissan is going to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CR

Crane

$91.10

4.6 (5.32%)

, CIR

Circor

$39.06

-0.77 (-1.93%)

10:11
07/23/19
07/23
10:11
07/23/19
10:11
Hot Stocks
Crane says would considering paying more than $48/share if Circor would engage »

Crane (CR) says on its Q2…

CR

Crane

$91.10

4.6 (5.32%)

CIR

Circor

$39.06

-0.77 (-1.93%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

  • 01

    Aug

  • 09

    Sep

  • 09

    Sep

10:10
07/23/19
07/23
10:10
07/23/19
10:10
General news
FX Action: The dollar »

FX Action: The dollar…

10:07
07/23/19
07/23
10:07
07/23/19
10:07
General news
Existing Home Sales data reported »

June Existing Home Sales…

10:07
07/23/19
07/23
10:07
07/23/19
10:07
General news
Richmond Fed Manufacturing Index Level data reported »

July Richmond Fed…

10:05
07/23/19
07/23
10:05
07/23/19
10:05
General news
FX Action: USD-JPY »

FX Action: USD-JPY has…

NVO

Novo Nordisk

$47.76

-0.65 (-1.34%)

10:04
07/23/19
07/23
10:04
07/23/19
10:04
Hot Stocks
Novo Nordisk granted orphan status for hemophilia B treatment »

The FDA granted Novo…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Sep

  • 25

    Sep

ALEC

Alector

$18.92

0.02 (0.11%)

10:03
07/23/19
07/23
10:03
07/23/19
10:03
Hot Stocks
Alector treatment of frontotemporal dementia granted FDA orphan status »

Alector's treatment…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Sep

KMB

Kimberly-Clark

$136.61

2.21 (1.64%)

10:03
07/23/19
07/23
10:03
07/23/19
10:03
Hot Stocks
Kimberly-Clark says 'broadly on track' with overall capital plan »

Says "broadly on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

REGN

Regeneron

$297.28

0.59 (0.20%)

10:02
07/23/19
07/23
10:02
07/23/19
10:02
Hot Stocks
Regeneron's pozelimab granted FDA orphan designation »

Regeneron…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Aug

  • 09

    Sep

CBRL

Cracker Barrel

$168.95

-0.03 (-0.02%)

10:01
07/23/19
07/23
10:01
07/23/19
10:01
Hot Stocks
Cracker Barrel to acquire non-controlling stake in Punch Bowl Social »

Cracker Barrel Old…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LCI

Lannett

$7.65

-0.78 (-9.25%)

10:00
07/23/19
07/23
10:00
07/23/19
10:00
Hot Stocks
Lannett falls -7.7% »

Lannett is down -7.7%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.